Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rae Lyn Burke is active.

Publication


Featured researches published by Rae Lyn Burke.


Journal of Clinical Investigation | 1993

Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

David M. Koelle; Michael A. Tigges; Rae Lyn Burke; Frank W. Symington; Stanley R. Riddell; Hiyam Abbo; Lawrence Corey

CD8+ cytotoxic T lymphocytes (CTL) clones with specificity for herpes simplex virus (HSV) were derived from two donors with genital HSV-2 infection. These CTL clones specifically lysed HSV-infected autologous B lymphoblastoid cells, but not HSV-infected fibroblasts. Exogenous peptide loading sensitized both cell types to lysis by an HSV-specific CTL clone of known specificity. HSV infection rendered fibroblasts refractory to peptide sensitization. HSV infection also rendered fibroblasts and keratinocytes insensitive to lysis by allospecific CD8+ CTL clones. Lysis of B lymphoblastoid cells in this system was only slightly reduced by HSV infection. Reduction of fibroblast allospecific lysis was dose and time dependent and was blocked by acyclovir, indicating the involvement of a late HSV gene product. HSV caused a reduction of fibroblast cell surface HLA class I antigen, at least in part due to reduction of synthesis of heavy chain-beta 2 microglobulin heterodimers. These results suggest that HSV-induced blockade of antigen presentation by cutaneous cells to CD8+ CTL may be a mechanism by which HSV limits or evades the immune response of the host.


Journal of Virology | 1990

Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells.

David C. Johnson; Rae Lyn Burke; Timothy J. Gregory


Journal of Immunology | 1996

Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.

Michael A. Tigges; Song Leng; David C. Johnson; Rae Lyn Burke


Journal of Virology | 1994

Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions

David M. Koelle; Lawrence Corey; Rae Lyn Burke; Roselyn J. Eisenberg; Gary H. Cohen; Rath Pichyangkura; Steven J. Triezenberg


Journal of Virology | 1992

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.

Michael A. Tigges; David M. Koelle; Karin Hartog; Rose E. Sekulovich; Lawrence Corey; Rae Lyn Burke


Nature Biotechnology | 1985

Antigen engineering in Yeast: Synthesis and assembly of hybrid hepatitis b surface antigen-herpes simplex 1 gd particles

Pablo Valenzuela; Doris Coit; M. Angelica Medina-Selby; Ching H. Kuo; Gary Van Nest; Rae Lyn Burke; Paulina Bull; Mickey S. Urdea; Pierre V. Graves


Journal of Immunology | 1988

The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.

L Sanchez-Pescador; Rae Lyn Burke; Gary Ott; G. A. Van Nest


Journal of Biological Chemistry | 1994

Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors.

Craig R. Brunetti; Rae Lyn Burke; Stuart Kornfeld; Walter Gregory; Frank R. Masiarz; Kevin S. Dingwell; David C. Johnson


Journal of Clinical Microbiology | 1999

Limits in Reliability of Glycoprotein G-Based Type-Specific Serologic Assays for Herpes Simplex Virus Types 1 and 2

D. Scott Schmid; Denise R. Brown; Rosane Nisenbaum; Rae Lyn Burke; D’Anna Alexander; Rhoda Ashley; Philip E. Pellett; William C. Reeves


Journal of Virology | 1987

Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells.

C Pachl; Rae Lyn Burke; L L Stuve; L Sanchez-Pescador; G Van Nest; F Masiarz; Dino Dina

Collaboration


Dive into the Rae Lyn Burke's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lawrence Corey

Fred Hutchinson Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gary Ott

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Scott Schmid

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Denise R. Brown

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge